Article Details
Retrieved on: 2021-04-12 17:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In 2020, several monoclonal antibodies were developed by pharmaceutical companies to target SARS-CoV-2, the virus that causes COVID-19.
Article found on: inside.upmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here